nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2026, 01, v.28 39-47
复方加味小柴胡汤对代谢相关脂肪性肝病的疗效及肠道菌群调节作用
基金项目(Foundation): 广东省中医药局科研项目(20221421); 东莞市社会发展科技项目(20221800900032)
邮箱(Email):
DOI: 10.13194/j.issn.1673-842X.2026.01.008
摘要:

目的 探讨复方加味小柴胡汤对代谢相关性脂肪性肝病(Metabolic associated fatty liver disease,MAFLD)小鼠的疗效和肠道菌群的影响。方法 雄性C57BL/J小鼠随机分成正常组、模型组、复方加味小柴胡汤低、高剂量组、易善复(多烯磷脂酰胆碱胶囊)组,每组10只。除正常组外,其余组给予高脂饲料诱导MAFLD模型并予不同剂量药物干预,共20周。检测小鼠体质量、肝湿重、肝指数;生化试剂盒检测血清天门冬氨酸氨基转氨酶(aspartate aminotransferase,AST)、丙氨酸氨基转氨酶(alanine aminotransferase,ALT)、总胆固醇(total cholesterol,TC)、甘油三酯(triglyceride,TG)、低密度脂蛋白胆固醇(low density lipoprotein cholesterol,LDL-C)、高密度脂蛋白胆固醇(high density lipoprotein cholesterol,HDL-C)、白细胞介素-6(interleukin-6,IL-6)、白细胞介素-17(interleukin-17,IL-17)、肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)、血清淀粉样蛋白A(serum amyloid A,SAA)、C-反应蛋白(C-reactive protein,CRP)含量;苏木素-伊红(hematoxylin-eosin,HE)染色观察肝脏组织形态;16S核糖体DNA(16S ribosomal DNA,16Sr DNA)基因测序分析小鼠肠道菌群变化。结果 与正常组比较,模型组小鼠体质量、肝湿重升高,肝指数下降;血清ALT、AST、TC、TG、LDL-C、HDL-C、IL-6、IL-17、TNF-α、CRP含量均升高;肝脏脂质蓄积增多,表明模型诱导成功。与模型组比较,复方加味小柴胡汤低、高剂量组和易善复组小鼠体质量、肝湿重、肝指数均降低,血清ALT、AST、TC、TG、LDL-C、HDL-C、IL-6、IL-17、TNF-α、CRP均降低,及肝组织脂肪变性程度均减轻。肠道菌群分析显示,与模型组比较,复方加味小柴胡汤能提高小鼠肠道菌群的丰富度和多样性;在门水平上,升高MAFLD小鼠的拟杆菌门和放线菌门;在属水平上,升高双歧杆菌属Bifidobacterium、乳杆菌属Lactobacillus和拟杆菌属Bacteroides_H丰度,发挥主要作用。结论 复方加味小柴胡汤可通过减轻脂质蓄积、抑制炎症、调节肠道菌群稳态来治疗MAFLD。

Abstract:

Objective To explore the effect of Modified Xiaochaihu Decoction(复方加味小柴胡汤)on the intestinal flora of mice with metabolically associated fatty liver disease(MAFLD). Methods Male C57 BL/J mice were randomly divided into normal group(NC),model group(HFD),Modified Xiaochaihu Decoction low-dose group(HFD+ZFL),high-dose group(HFD+ZFH)and Polyene phosphatidylcholine group(HFD+PPC),with 10 mice in each group. Except the normal group,the other groups were given high-fat diet induced MAFLD model and different doses of drug intervention for a total of 20 weeks. Body mass,liver wet weight and liver index were detected. Detection of serum aspartate aminotransferase(AST),alanine aminotransferase(ALT),total cholesterol(TC),triglyceride(TG),low density lipoprotein cholesterol(LDL-C),high density lipoprotein cholesterol(HDL-C),interleukin-6(IL-6),interleukin-17(IL-17)by biochemical kit,tumor necrosis factor-α(TNF-α),serum amyloid A(SAA),C-reactive protein(CRP)content;The liver morphology was observed by hematoxylin-eosin(HE)staining. 16S ribosomal DNA(16 Sr DNA)gene sequencing was used to analyze the changes of intestinal flora in mice. Results The results showed that compared with NC,the body weight and liver wet weight of mice in HFD increased,while the liver index decreased. Serum ALT,AST,TC,TG,LDL-C,HDL-C,IL-6,IL-17,TNF-α and CRP levels were increased. Liver lipid accumulation increased,indicating successful model induction. Compared with HFD,the body weight,liver wet weight and liver index of the mice in HFD+ZFL,HFD+ZFH and HFD+PPC were decreased. Serum levels of ALT,AST,TC,TG,LDL-C,HDL-C,IL-6,IL-17,TNF-α and CRP of mice in HFD+ZFL,HFD+ZFH and HFD+PPC were decreased. The degree of hepatic steatosis of mice in HFD+ZFL,HFD+ZFH and HFD+PPC were reduced. Intestinal flora analysis showed that compared with HFD,Modified Xiaochaihu Decoction could improve the richness and diversity of intestinal flora in mice. At the phylum level,Bacteroidetes and Actinomycetes were increased in MAFLD mice. At the genus level,it plays a major role in increasing the abundance of Bifidobacterium,Lactobacillus and Bacteroides_H. Conclusion Modified Xiaochaihu Decoction can treat MAFLD by reducing lipid accumulation,inhibiting inflammation and regulating intestinal flora homeostasis.

参考文献

[1]GOFTON C,UPENDRAN Y,ZHENG M-H,et al. MAFLD:how is it different from NAFLD ?[J]. Clin Mol Hepatol,2023,29:S17-S31.

[2]SUBRAMANIAN P,HAMPE J,TACKE F,et al. Fibrogenic pathways in metabolic dysfunction associated fatty liver disease(MAFLD)[J]. Int J Mol Sci,2022,23(13):6996.

[3]秦宇,张明香.中医药治疗代谢相关脂肪性肝病研究进展[J].临床合理用药,2025,18(12):168-171.

[4]贾琛琛,岳蓉,向文雯,等.基于“肠-肝轴”探讨逍遥散加味方对代谢相关脂肪性肝病小鼠肠道屏障及肠道菌群的影响[J].中国中药杂志,2024,49(16):4499-4509.

[5]梅海云,张永文,吴秉司,等.基于糖代谢和胰岛素抵抗评估益气养阴法治疗气阴两虚型2型糖尿病的疗效[J].辽宁中医杂志,2024,51(6):123-126.

[6]罗天鸽,常占杰,闫瑞娟,等.从“轻可去实开玄府”辨治代谢相关脂肪性肝病[J].中西医结合肝病杂志,2025,35(4):464-467.

[7]王晨,蒋明芹.中医治疗痰湿内阻型非酒精性脂肪性肝病的研究进展[J].中国民间疗法,2024,32(9):126-129.

[8]黄兴琳,杨泽荣,李林哲,等.基于茯苓菌核的3种药材化学成分及药理研究进展[J].中华中医药学刊,2025,43(4):90-104.

[9]李美娟,吕冠华.小柴胡汤在消化系统疾病的作用机制研究概述[J].实用中医内科杂志,2024,38(11):99-102.

[10]首第文,周永健,徐豪明,等.代谢相关性脂肪性肝病小鼠不同高脂饮食时期血糖水平和肠道菌群变化动态分析[J].实用肝脏病杂志,2021,24(5):661-664.

[11]庄莉,阮明文,高智杰.低分子肝素钠治疗急性缺血性结肠炎的临床有效性分析[J].中外医疗,2023,42(28):81-84.

[12]赵文廷,卢秉久,何佳,等.基于“湿胜阳微”理论探讨肠道菌群在代谢相关脂肪性肝病中的作用[J].辽宁中医药大学学报,2023,25(11):147-152.

[13]马新蕾,周正,吴佩珊,等.基于“肠肝轴-菌群失调”探讨加味小柴胡汤治疗代谢相关脂肪性肝病的随机对照研究[J].四川中医,2024,42(12):100-103.

[14]吴山永,姜宁华,石彦波,等.小柴胡汤联合厄贝沙坦对高血压患者肠道菌群及脂代谢影响[J].中华中医药学刊,2022,40(1):169-172.

[15]范建高,徐小元,南月敏,等.代谢相关(非酒精性)脂肪性肝病防治指南(2024年版)[J].实用肝脏病杂志,2024,27(4):494-510.

[16]陈孟桥,尚靖.“肠道菌群-肠-肝轴”在非酒精性脂肪肝病中的作用研究进展[J].医学诊断,2023(2):237-249.

[17]纪童童,李鑫飞,于岩岩,等.代谢相关脂肪性肝病生活方式干预治疗进展[J].临床肝胆病杂志,2023,39(8):1789-1796.

[18]方铃铃,林玥宏,李勤,等.苓荷颗粒治疗超重/肥胖型代谢相关脂肪性肝病140例临床观察[J/OL].世界中医药,2025:1-12.(2025-03-19). https://kns.cnki.net/KCMS/detail/detail.aspx ?filename=SJZA20250317001&dbname=CJFD&dbcode=C JFQ.

[19]刘俊,杨霞兰,万浪.小柴胡汤治疗肝胃郁热型慢性萎缩性胃炎临床观察[J].光明中医,2024,39(3):520-523.

[20]王威宇,王玉昆,陈一笑,等.柴胡有效成分及经典名方抗代谢相关脂肪性肝病的药理与临床研究进展[J].药物评价研究,2023,46(11):2490-2495.

[21]彪雅宁,储心乔,张睦清,等.丹参泽泻汤对代谢相关脂肪性肝病大鼠AMPK/Nrf2信号通路的调节作用[J].中国实验方剂学杂志,2023,29(1):67-74.

[22]俞瑾,俞超芹,侯丽辉,等.多囊卵巢综合征证治方案研究及应用[J].中国中西医结合杂志,2021,41(2):246-251.

[23]王茜,曾阳.基于“微生物-肠-脑轴”理论的三部穴位干预法治疗内脏型肥胖伴高脂血症的临床研究[J].针灸临床杂志,2023,39(12):20-26.

[24]孙守桦,王莉.基于肠道菌群从痰证角度论肥胖[J].中国处方药,2023,21(5):184-188.

[25]陈倩,唐子淇,丁银元.肠道菌群影响代谢性疾病血管钙化的研究进展[J].中国动脉硬化杂志,2025,33(3):194-201.

[26]王昊阳,杨明华,梅璐.肠道菌群与胆汁酸代谢在代谢相关脂肪性肝病的发生发展中的作用[J].中国微生态学杂志,2023,35(8):989-993.

[27]周响,韩宇.益生菌辅助治疗代谢相关脂肪性肝病的临床观察[J].中国微生态学杂志,2023,35(1):78-83.

[28]HAMAMAH S,IATCU OC,COVASA M. Dietary influences on gut microbiota and their role in metabolic dysfunction-associated steatotic liver disease(MASLD)[J]. Nutrients,2025,17(1):143.

基本信息:

DOI:10.13194/j.issn.1673-842X.2026.01.008

中图分类号:R285.5

引用信息:

[1]李海怡,李甜丹,陈迎,等.复方加味小柴胡汤对代谢相关脂肪性肝病的疗效及肠道菌群调节作用[J].辽宁中医药大学学报,2026,28(01):39-47.DOI:10.13194/j.issn.1673-842X.2026.01.008.

基金信息:

广东省中医药局科研项目(20221421); 东莞市社会发展科技项目(20221800900032)

投稿时间:

2025-03-27

投稿日期(年):

2025

终审时间:

2025-06-30

终审日期(年):

2025

审稿周期(年):

1

发布时间:

2025-07-08

出版时间:

2025-07-08

网络发布时间:

2025-07-08

检 索 高级检索

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文